13G Filing: Knoll Capital Management Files on Corbus Pharmaceuticals Holdings, Inc. (CRBP)

 

Cusip No.  21833P103

13G

Page 5 of 7 Pages

 

Item 1(a).

Name of Issuer:

 

Corbus Pharmaceuticals Holdings, Inc. (the “Issuer”)

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

 

100 River Ridge Drive

Norwood, Massachusetts 02062

Item 2(a).

Name of Persons Filing:

 

Knoll Capital Management LP (“KCMLP”)

Fred Knoll (“Knoll”)

Gakasa Holdings, LLC. (“Gakasa”)

Item 2(b).

Address of Principal Business Office or, if none, Residence:

 

The principle business address for each of KCMLP, Knoll and
Gakasa is 5 East 44^th Street, Suite 12, New York, NY 10017

Item 2(c).

Citizenship:

KCMLP is a limited partnership formed and existing under the
laws of the State of Delaware.

Knoll is a citizen of the United States.

Gakasa is a limited liability company organized under the laws
of the State of Florida.

 

Item 2(d).

Title of Class of Securities:

 

This statement on Schedule 13G is being filed with respect to
Common Stock, $0.0001 par value per share (the “Common Stock”) of the issuer.

 

Item 2(e).

CUSIP Number:

21833P103

Item 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable

	(a)	¨	Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o);
	(b)	¨	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c);
	(c)	¨	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c);
	(d)	¨	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	¨	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
	(f)	¨	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
	(g)	¨	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	¨	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	¨	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
	(j)	¨	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
	(k)	¨	Group, in accordance with § 240.13d-1(b)(1)(ii)(K).